# Study of Innate Host Immune Response to C. Glabrata Clinical Isolates Resistant to Echinocandins: Impact on the Management of Candidemia in High-risk Patients

> **NCT03652194** · — · UNKNOWN · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 21 (actual)

## Conditions studied

- Candidemia of C. Glabrata

## Interventions

- **OTHER:** in vitro evaluation of epithelial immune response during C. glabrata infection
- **OTHER:** study of the impact of resistance phenotype acquisition on the virulence of C. glabrata isolates

## Key facts

- **NCT ID:** NCT03652194
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2019-01
- **Final completion:** 2019-06
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2018-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03652194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03652194, "Study of Innate Host Immune Response to C. Glabrata Clinical Isolates Resistant to Echinocandins: Impact on the Management of Candidemia in High-risk Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03652194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*